Acer Therapeutics Depreciation & Amortization 2011-2026 | ACER

Annual Depreciation & Amortization Acer Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66 K	70.9 K	70.8 K	58.3 K	27.7 K	4 K	238 K	351 K	388 K	336 K	304 K	210 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
388 K	4 K	177 K

Quarterly Depreciation & Amortization Acer Therapeutics

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	15.5 K	-	52.8 K	38.8 K	20.6 K	-	51.2 K	32.6 K	14.6 K	-	53.1 K	35.4 K	17.7 K	-	40.6 K	27.1 K	9.55 K	-	16.6 K	11 K	6.22 K	-	2.71 K	-	-	-	52 K	65.7 K	72.6 K	-	89 K	94 K	97 K	-	97.4 K	98.7 K	95.6 K	-	90.9 K	88.9 K	78.3 K	-	81.5 K	76.5 K	67.4 K	-	56.9 K	70.7 K	29.6 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
98.7 K	2.71 K	52.8 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Benitec Biopharma BNTC	66 K	$ 10.98	-4.52 %	$ 452 M	USA
Milestone Pharmaceuticals MIST	114 K	$ 1.36	-20.0 %	$ 45.5 M	Canada
Pharming Group N.V. PHAR	7.28 M	$ 15.36	-0.71 %	$ 7.59 B	Niderland
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
PainReform Ltd. PRFX	7 K	$ 2.28	-0.44 %	$ 1.03 M	Israel
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Assembly Biosciences ASMB	129 K	$ 28.46	3.45 %	$ 319 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.37	-4.2 %	$ 350 M	Britain
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Axsome Therapeutics AXSM	503 K	$ 156.92	-1.23 %	$ 7.81 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	18.4 M	$ 3.4	-3.68 %	$ 1.02 B	Canada
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
BioMarin Pharmaceutical BMRN	79.6 M	$ 54.13	-1.64 %	$ 10.4 B	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Compugen Ltd. CGEN	461 K	$ 2.09	-0.95 %	$ 195 M	Israel
Coherus BioSciences CHRS	1.3 M	$ 1.52	-5.59 %	$ 178 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Corbus Pharmaceuticals Holdings CRBP	233 K	$ 8.6	-3.8 %	$ 115 M	USA
Curis CRIS	203 K	$ 0.77	1.89 %	$ 4.86 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA